Literature DB >> 11283065

Biotyping of Penicillium marneffei reveals concentration-dependent growth inhibition by galactose.

S S Wong1, T Y Ho, A H Ngan, P C Woo, T L Que, K Y Yuen.   

Abstract

Thirty-two isolates of the dimorphic fungus Penicillium marneffei were studied for their biochemical properties. All isolates possessed the enzyme urease and were inhibited by 500 mg of cycloheximide per liter. No strain fermented glucose, and thus no strain fermented any of the other five sugars tested. All assimilated glucose, maltose, and cellobiose; only one of the isolates did not assimilate salicin. Totals of 65.6, 84.4, and 71.9% of the isolates assimilated trehalose, xylose, and nitrate, respectively. Twelve strains possessed the enzyme beta-galactosidase. Overall, 17 different biotypes were recognized, but no association was found between the human immunodeficiency virus status of the patients and the biotype. A novel finding of concentration-dependent growth inhibition of P. marneffei by galactose is described. Inhibition of growth occurred at a low concentration of galactose (0.015 to 0.25%) when galactose was the sole carbon source in the medium. Morphological changes of the fungal cells were observed in the presence of galactose.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283065      PMCID: PMC87948          DOI: 10.1128/JCM.39.4.1416-1421.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Analysis of the enzymatic activity of mycelial and yeast phases of Penicillium marneffei.

Authors:  S Youngchim; N Vanittanakom; A J Hamilton
Journal:  Med Mycol       Date:  1999-12       Impact factor: 4.076

2.  Immunoreactivity of a 38-kilodalton Penicillium marneffei antigen with human immunodeficiency virus-positive sera.

Authors:  P Chongtrakool; S C Chaiyaroj; V Vithayasai; S Trawatcharegon; R Teanpaisan; S Kalnawakul; S Sirisinha
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Molecular evidence for strain dissemination of Penicillium marneffei: an emerging pathogen in Taiwan.

Authors:  P R Hsueh; L J Teng; C C Hung; J H Hsu; P C Yang; S W Ho; K T Luh
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

4.  Reactive hemophagocytic syndrome associated with Penicillium marneffei infection.

Authors:  C S Chim; C Y Fong; S K Ma; S S Wong; K Y Yuen
Journal:  Am J Med       Date:  1998-02       Impact factor: 4.965

5.  MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei.

Authors:  L Cao; C M Chan; C Lee; S S Wong; K Y Yuen
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

6.  Diagnostic antigenemia tests for penicilliosis marneffei.

Authors:  L Kaufman; P G Standard; M Jalbert; P Kantipong; K Limpakarnjanarat; T D Mastro
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients.

Authors:  L Cao; K M Chan; D Chen; N Vanittanakom; C Lee; C M Chan; T Sirisanthana; D N Tsang; K Y Yuen
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

8.  Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial.

Authors:  M Uhari; T Kontiokari; M Koskela; M Niemelä
Journal:  BMJ       Date:  1996-11-09

9.  Identification and purification of specific Penicillium marneffei antigens and their recognition by human immune sera.

Authors:  L Jeavons; A J Hamilton; N Vanittanakom; R Ungpakorn; E G Evans; T Sirisanthana; R J Hay
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

10.  Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay.

Authors:  V Desakorn; M D Smith; A L Walsh; A J Simpson; D Sahassananda; A Rajanuwong; V Wuthiekanun; P Howe; B J Angus; P Suntharasamai; N J White
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

View more
  4 in total

Review 1.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Nucleotide sequence-based analysis for determining the molecular epidemiology of Penicillium marneffei.

Authors:  Brent A Lasker
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  Analysis of polymorphic microsatellite markers for typing Penicillium marneffei isolates.

Authors:  Brent A Lasker; Yuping Ran
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of Talaromyces marneffei Isolates from Fujian and Guangxi (China).

Authors:  Lili Fang; Minxue Liu; Chunlan Huang; Jian Guo; Xiaobo Ma; Yanqing Zheng; Wenjuan Wu; Jiangshan Huang; Heping Xu
Journal:  Infect Drug Resist       Date:  2022-07-01       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.